Cite
HARVARD Citation
Wesolowski, R. et al. (2020). Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]‐Fluorothymidine Positron Emission Tomography Biomarker Study. Oncologist. pp. e1158-e1169. [Online].